BETAHISTINE-ZP betahistine dihydrochloride 16mg tablets blister pack

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

공공 평가 보고서 공공 평가 보고서 (PAR)
25-11-2017

유효 성분:

betahistine dihydrochloride, Quantity: 16 mg

제공처:

Medis Pharma Pty Ltd

INN (International Name):

betahistine dihydrochloride

약제 형태:

Tablet

구성:

Excipient Ingredients: crospovidone; lactose monohydrate; povidone; stearic acid; colloidal anhydrous silica; microcrystalline cellulose

관리 경로:

Oral

패키지 단위:

100 tablets, 25 tablets, 10 tablets

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

Meniere?s Syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

제품 요약:

Visual Identification: White to almost white, round, flat bevelled edged tablets embossed B16 on one side and scored on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2015-11-10